Skip to main content

Advertisement

SpringerLink
Log in

Primary non-Hodgkin lymphomas in the small and large intestine: clinicopathological characteristics and management of 40 patients

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

To investigate the clinicopathological characteristics and optimal treatment modalities of primary non-Hodgkin lymphoma (NHL) in the small and large intestine. Forty patients with primary NHL in the small and large intestine were studied retrospectively. All cases were reclassified according to the World Health Organization (WHO) classification of lymphoma in 2001. Fourteen patients had primary disease in the small intestine, which were all of B-cell origin with diffuse large B-cell lymphoma (DLBCL) diagnosed in 5 of 14 (35.7%) patients and mucosa-associated lymphoid tissue (MALT) lymphoma in 8 of 14 (57.1%) patients. Ileum was the most commonly involved site (8 of 14 patients, 57.1%), followed by jejunum (2 of 14 patients, 14.3%) and duodenum (1 of 14 patients, 7.1%). Twenty-five patients had primary colorectal lymphoma, with B-cell origin accounting for 92.0% and T-cell origin for 8.0% of these patients. The ileocaecal region has the highest involved rate (13 of 25 patients, 52.0%), followed by colon (7 of 25 patients, 28.0%) and rectum (3 of 25 patients, 12.0%). Compared with surgery alone, post-operation chemotherapy or chemoradiotherapy can significantly improve DLBCL patients’ event-free survival (EFS). However, no post-operation treatment modality can improve OS or EFS for patients with MALT lymphoma. B-cell lymphoma is the most common pathological type of intestinal lymphomas. Chemotherapy-containing treatment modality is an effective way to improve intestinal lymphoma patients’ EFS, especially for those with DLBCL subtype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Nakamura S, Matsumoto T, Iida M, Yao T, Tsuneyoshi M. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. 2003;97:2462–73.

    Article  PubMed  Google Scholar 

  2. Yoshino T, Miyake K, Ichimura K, et al. IIncreased incidence of follicular lymphoma in the duodenum. Am J Surg Pathol. 2000;24:688–93.

    Article  CAS  PubMed  Google Scholar 

  3. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin’s lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol. 1997;8:727–37.

    Article  CAS  PubMed  Google Scholar 

  4. Amer M, el-Akkad S. Gastrointestinal lymphoma in adults: clinical features and management of 300 cases. Gastroenterology. 1994;106:846–58.

    Article  CAS  PubMed  Google Scholar 

  5. Wong MT, Eu KW. Primary colorectal lymphomas. Colorectal Dis. 2006;8:586–91.

    Article  CAS  PubMed  Google Scholar 

  6. Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer. 1978;42:693–707.

    Article  CAS  PubMed  Google Scholar 

  7. Kashimura A, Murakami T. Malignant lymphoma of the large intestine-15-year experience and review of literature. Gastroenterol Jpn. 1976;11:141–7.

    CAS  PubMed  Google Scholar 

  8. Henry CA, Berry RE. Primary lymphoma of the large intestine. Am Surg. 1988;54:262–6.

    CAS  PubMed  Google Scholar 

  9. Dragosics B, Bauer P, Radaszkiewicz T. Primary gastrointestinal non-Hodgkin’s lymphomas: a retrospective clinicopathologic study of 150 cases. Cancer. 1985;55:1060–73.

    Article  CAS  PubMed  Google Scholar 

  10. Nakamura S, Matsumoto T, Takeshita M, et al. clinicopathologic study of primary small intestine lymphoma: prognostic significance of mucosa-associated lymphoid tissue-derived lymphoma. Cancer. 2000;88:286–94.

    Article  CAS  PubMed  Google Scholar 

  11. Koch P, Probst A, Berdel WE, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol. 2005;23:7050–9.

    Article  PubMed  Google Scholar 

  12. Kim YH, Lee JH, Yang SK, et al. Primary colon lymphoma in Korea: a KASID (Korean Association for the Study of Intestinal Diseases) Study. Dig Dis Sci. 2005;50:2243–7.

    Article  PubMed  Google Scholar 

  13. kohno S, Ohshima K, Yoneda S, Kodama T, Shirakusa T, Kikuchi M. Clinicopathological analysis of 143 primary malignant lymphomas in the small and large intestines based on the new WHO classification. Histopathology. 2003;43:135–43.

    Article  CAS  PubMed  Google Scholar 

  14. Bairey O, Ruchlemer R, Shpilberg O. Non-Hodgkin’s lymphomas of the colon. Isr Med Assoc J. 2006;8:832–5.

    PubMed  Google Scholar 

  15. Gan JL, Tang ZJ. Clinical, endoscopic and pathological features of primary colorectal non-Hodgkin lymphoma: 24 cases report. Zhonghua Wei Chang Wai Ke Za Zhi. 2006;9:502–5.

    PubMed  Google Scholar 

  16. Bai CM, Yang T, Xu Y, et al. Clinical analysis of 32 primary intestinal non-Hodgkin’s lymphoma. Zhonghua Zhong Liu Za Zhi. 2006;28:142–4.

    PubMed  Google Scholar 

  17. Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol. 2001;19:3861–73.

    Article  CAS  PubMed  Google Scholar 

  18. Ibrahim EM, Ezzat AA, El-Weshi AN, et al. Primary intestinal diffuse large B-cell non-Hodgkin’s lymphoma: clinical features, management, and prognosis of 66 patients. Ann Oncol. 2001;12:53–8.

    Article  CAS  PubMed  Google Scholar 

  19. Fan CW, Changchien CR, Wang JY, et al. Primary colorectal lymphoma. Dis Colon Rectum. 2000;43:1277–82.

    Article  CAS  PubMed  Google Scholar 

  20. Haselkorn T, Whittemore AS, Lilienfeld DE. Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control. 2005;16:781–7.

    Article  PubMed  Google Scholar 

  21. Morton JE, Leyland MJ, Vaughan Hudson G, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: a review of 175 British National Lymphoma Investigation cases. Br J Cancer. 1993;67:776–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Bruneton JN, Thyss A, Bourry J, Bidoli R, Schneider M. Colonic and rectal lymphomas. A report of six cases and review of the literature. Rofo. 1983;138:283–7.

    Article  CAS  PubMed  Google Scholar 

  23. Kajanti M, Karkinen-Jaaskelainen M, Rissanen P. Primary gastrointestinal non-Hodgkin lymphoma. A review of 36 cases. Acta Oncol. 1988;27:51–5.

    Article  CAS  PubMed  Google Scholar 

  24. Brands F, Monig SP, Raab M. Treatment and prognosis of gastric lymphoma. Eur J Surg. 1997;163:803–13.

    CAS  PubMed  Google Scholar 

  25. Crump M, Gospodarowicz M, Shepherd FA. Lymphoma of the gastrointestinal tract. Semin Oncol. 1999;26:324–37.

    CAS  PubMed  Google Scholar 

  26. Fischbach W, Dragosics B, Kolve-Goebeler ME, et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology. 2000;119:1191–202.

    Article  CAS  PubMed  Google Scholar 

  27. Azab MB, Henry-Amar M, Rougier P, et al. Prognostic factors in primary gastrointestinal non-Hodgkin’s lymphoma. A multivariate analysis, report of 106 cases, and review of the literature. Cancer. 1989;64:1208–17.

    Article  CAS  PubMed  Google Scholar 

  28. Bellesi G, Alterini R, Messori A, et al. Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin’s lymphomas. Br J Cancer. 1989;60:244–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Salles G, Herbrecht R, Tilly H, et al. Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d’Etude des Lymphomes Agressifs. Am J Med. 1991;90:77–84.

    Article  CAS  PubMed  Google Scholar 

  30. Schmidt WP, Schmitz N, Sonnen R. Conservative management of gastric lymphoma: the treatment option of choice. Leuk Lymphoma. 2004;45:1847–52.

    Article  PubMed  Google Scholar 

  31. Aviles A, Nambo MJ, Neri N, et al. The role of surgery in primary gastric lymphoma: results of a controlled clinical trial. Ann Surg. 2004;240:44–50.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Aviles A, Nambo MJ, Neri N, Talavera A, Cleto S. Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial. Med Oncol. 2005;22:57–62.

    Article  PubMed  Google Scholar 

  33. Nakamura S, Matsumoto T, Suekane H, et al. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Cancer. 2005;104:532–40.

    Article  PubMed  Google Scholar 

  34. Park YH, Lee SH, Kim WS, et al. CHOP followed by involved field radiotherapy for localized primary gastric diffuse large B-cell lymphoma: results of a multi center phase II study and quality of life evaluation. Leuk Lymphoma. 2006;47:1253–9.

    Article  CAS  PubMed  Google Scholar 

  35. Mihaljevic B, Nedeljkov-Jancic R, Vujicic V, Antic D, Jankovic S, Colovic N. Primary extranodal lymphomas of gastrointestinal localizations: a single institution 5-yr experience. Med Oncol. 2006;23:225–35.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China

    Bo Li, Yuan-kai Shi, Xiao-hui He, Shuang-mei Zou, Sheng-yu Zhou, Mei Dong, Jian-liang Yang, Peng Liu & Li-yan Xue

  2. No 17, Panjiayuan Nanli, Chaoyang District, Beijing, China, 100021

    Yuan-kai Shi

Authors
  1. Bo Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuan-kai Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiao-hui He
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shuang-mei Zou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sheng-yu Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mei Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jian-liang Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Peng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Li-yan Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuan-kai Shi.

About this article

Cite this article

Li, B., Shi, Yk., He, Xh. et al. Primary non-Hodgkin lymphomas in the small and large intestine: clinicopathological characteristics and management of 40 patients. Int J Hematol 87, 375–381 (2008). https://doi.org/10.1007/s12185-008-0068-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-008-0068-5

Keywords

Search

Navigation